Key takeaways
Anoro Ellipta and Trelegy Ellipta are two inhaled medications used for COPD management. While Anoro contains two ingredients targeting airway relaxation, Trelegy includes an additional corticosteroid to reduce inflammation and can be used for both COPD and asthma treatment. It is important to note that neither medication can be used as a rescue inhaler for sudden symptom flare-ups such as wheezing or shortness of breath.
Insurance plans generally cover both Anoro and Trelegy, but out-of-pocket costs vary. Utilizing resources like SingleCare coupons can significantly reduce expenses for uninsured patients.
Both medications share common adverse effects, but Trelegy, with its corticosteroid component, requires additional monitoring for certain conditions.
Consult your healthcare provider for more information and medical advice about your condition(s) and treatment.
Anoro Ellipta and Trelegy Ellipta are two brand-name medications indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. Trelegy can also be used to prevent and control asthma symptoms and exacerbations (worsening of symptoms). Asthma and COPD symptoms may include shortness of breath, wheezing, and cough.
These medications, which are both made by the pharmaceutical company GlaxoSmithKline (GSK), are inhaled by mouth. They do not treat an acute or sudden attack. Instead, they are used daily to prevent and control symptoms. Each medication contains more than one ingredient, which we will explain below. While Anoro Ellipta and Trelegy Ellipta have some similarities, they have differences as well. Continue reading to learn more about both medications.
Anoro vs. Trelegy: Key differences
Anoro Ellipta contains two ingredients: umeclidinium, which is classified as an anticholinergic (also known as a long-acting muscarinic antagonist), and vilanterol, which is a long-acting beta agonist (LABA). The dose is one puff by mouth once a day. Anoro works by relaxing smooth muscles in the airways of the lungs, making it easier to breathe.
Trelegy contains the same two ingredients, along with fluticasone furoate, an inhaled corticosteroid. Like Anoro, the dose is one puff by mouth once a day. After using Trelegy, patients should rinse their mouths with water and spit. This helps prevent a yeast infection of the mouth and throat. Trelegy works the same way as Anoro, but the addition of fluticasone helps decrease inflammation in the airways, making it easier to breathe.
Note that in this article, we refer to Anoro and Anoro Ellipta interchangeably—and Trelegy and Trelegy Ellipta interchangeably. Anoro and Trelegy are the medications’ names, while Ellipta is the type of inhaler. An Ellipta inhaler is a type of dry powder inhaler that was developed to deliver once-daily medication to people with asthma or COPD.
Compare Anoro vs. Trelegy key differences |
||
---|---|---|
Anoro | Trelegy | |
Drug class | Anticholinergic and LABA | Inhaled corticosteroid (ICS), anticholinergic, and LABA |
Brand/generic status | Brand | Brand |
What is the generic name? | The active ingredients are umeclidinium/vilanterol, but there is no generic available | The active ingredients are fluticasone furoate, umeclidinium, and vilanterol, but there is no generic available |
What form(s) does the drug come in? | Dry powder inhaler (inhalation powder)
|
Dry powder inhaler (inhalation powder)
|
What is the standard dosage? | 1 puff inhaled by mouth once a day | 1 puff inhaled by mouth once a day; rinse mouth with water and spit after using |
How long is the typical treatment? | Long-term | Long-term |
Who typically uses the medication? | Adults | Adults |
Anoro vs. Trelegy: Conditions treated
Anoro and Trelegy are both approved by the Food and Drug Administration (FDA) for the maintenance treatment of COPD in adults. Additionally, Trelegy can be used in adult patients with asthma, to prevent and control symptoms. Neither drug is FDA approved for use in individuals under the age of 18 years.
Note: Anoro and Trelegy do not treat sudden, acute symptoms such as an asthma attack or sudden difficulty breathing.
Compare Anoro vs. Trelegy conditions treated |
||
---|---|---|
Condition | Anoro | Trelegy |
COPD maintenance treatment (adults) | Yes | Yes |
Asthma maintenance treatment (adults) | No | Yes |
Is Trelegy better than Anoro?
A clinical trial published in the New England Journal of Medicine studied over 10,000 people with COPD over the period of one year. The researchers compared Trelegy (which has three ingredients) to two different inhalers (Anoro and Breo Ellipta), each of which has two ingredients. The primary outcome was the annual rate of moderate or severe exacerbations of COPD during treatment.
The researchers found that people who took Trelegy had a lower rate of exacerbations, as well as a lower rate of COPD-related hospitalizations. They also reported better lung function and a better health-related quality of life. However, people who took Anoro had a lower rate of pneumonia as a side effect of medication than those who took Breo or Trelegy.
There are many factors that contribute to deciding the best medication for a patient, including the benefits and risks of each treatment, so it is important to consult with a healthcare provider. Only a healthcare provider can determine the best treatment option for your condition, considering individual factors such as symptoms, medical conditions, medical and family history, potential side effects, and drug interactions.
Anoro vs. Trelegy: Insurance coverage and cost comparison
Insurance plans and Medicare prescription plans often provide some type of coverage for Anoro or Trelegy, but out-of-pocket costs will vary by plan. You can always contact your health insurance provider for more information and the most recent pricing estimates on your medication. Similar drugs for those with breathing problems who may want to explore other options with their healthcare provider include inhalers like Advair, Symbicort, Spiriva, or Breo Ellipta.
For uninsured patients paying out of pocket, the average retail price of one 14-blister 62.5 mcg/25 mcg inhaler is about $170. Using a SingleCare prescription discount card or coupon can lower the price to $98, depending on the pharmacy.
For uninsured patients, a Trelegy inhaler costs approximately $880 for one 60-blister 100 mcg/62.5 mcg/25 mcg inhaler, but using a SingleCare card or coupon can bring the price down to $504.
Compare Anoro vs. Trelegy cost & coverage | ||
---|---|---|
Anoro | Trelegy | |
Typically covered by insurance? | Yes | Yes |
Typically covered by Medicare Part D? | Yes | Yes |
Quantity | 1 inhaler | 1 inhaler |
SingleCare cost* | $98 | $504 |
*Cost at time of publication. Costs fluctuate and vary by pharmacy.
Anoro vs. Trelegy side effects
Common side effects of Anoro include:
- Sore throat
- Common cold symptoms
- Arm or leg pain
- Chest pain
- Sinus infection
- Constipation
- Muscle spasms
- Lower respiratory tract infection
- Diarrhea
- Neck pain
Common Trelegy side effects for people with COPD include:
- Upper respiratory tract infection
- Flu
- Sinus infection
- Sore throat, runny nose, cough
- Pneumonia
- Bronchitis
- Yeast infection of the mouth or throat
- Headache
- Back pain
- Joint pain
- Altered taste
- Stomach problems such as stomach flu, constipation, or diarrhea
- Urinary tract infection (UTI)
- Abnormal voice
Common Trelegy side effects for people with asthma include:
- Sore throat
- Common cold, runny nose
- Flu
- Upper respiratory tract infection
- Bronchitis
- Sinus infection
- UTI
- Headache
- Back pain
In rare cases, serious side effects may occur. People with symptoms of an allergic reaction, such as hives, difficulty breathing, or swelling of the face, lips, tongue, or throat, should seek emergency medical attention.
This is not a full list of side effects, and other side effects can occur. Consult your healthcare provider or pharmacist for more information about the side effects of Anoro or Trelegy.
Anoro and Trelegy drug interactions
Before taking Anoro or Trelegy, tell your healthcare professional about all the medications you take, including prescription drugs, over-the-counter medications, vitamins, and supplements.
Anoro and Trelegy have many of the same drug interactions, such as beta blockers, diuretics, certain antidepressants, and more.
This is not a full list of drug interactions, and others may occur. Talk to your healthcare provider about drug interactions and how they may affect you.
Compare Anoro vs. Trelegy drug interactions |
|||
---|---|---|---|
Drug | Drug class | Interacts with Anoro? | Interacts with Trelegy? |
Ketoconazole | Antifungals | Yes | Yes |
Atenolol
Metoprolol |
Beta blockers | Yes | Yes |
Phenelzine
Tranylcypromine |
Monoamine oxidase inhibitors (MAOIs) | Yes | Yes |
Amitriptyline
Nortriptyline |
Tricyclic antidepressants | Yes | Yes |
Furosemide | Certain diuretics (water pills) | Yes | Yes |
Certain cold or allergy medicines
Overactive bladder medications Parkinson’s disease medications |
Anticholinergic drugs | Yes | Yes |
Anoro and Trelegy drug warnings
- Before you take Anoro or Trelegy, tell your healthcare provider about all of your medical conditions. This includes heart problems, seizures, thyroid problems, diabetes, glaucoma, bladder or urinary problems, and prostate problems as well as if you are pregnant, planning to become pregnant, or breastfeeding.
- If you have an allergy to milk proteins, consult your healthcare provider before using Anoro or Trelegy. People with a severe milk protein allergy should not use Anoro or Trelegy.
- People with asthma who take a LABA type of medicine should always take an inhaled corticosteroid (ICS). This is because taking a LABA alone can increase the risk of asthma-related death in people with asthma. This can be done as a combination inhaler or two separate inhalers. Trelegy contains three ingredients, two of which are an ICS and a LABA. Anoro contains a LABA, but not an ICS—however, it is not FDA approved for use in people with asthma.
- Anoro and Trelegy do not treat acute symptoms, including acutely deteriorating COPD. They are not rescue inhalers.
- Do not use another LABA medication along with Anoro or Trelegy, as an overdose may occur.
- People who experience paradoxical bronchospasm (a rare side effect in which the lungs constrict instead of relax after using an inhaler) should stop taking Anoro or Trelegy, use their rescue inhaler (a short-acting bronchodilator such as albuterol), and contact their healthcare provider right away or get urgent medical help.
- See your healthcare provider right away if you have symptoms of glaucoma, such as eye pain or changes in vision.
- Because Trelegy contains an ICS, people who use Trelegy will need additional monitoring, such as for bone mineral density, glaucoma, and signs of infection, including tuberculosis and other types of bacterial, fungal, or viral infections.
Sources
- The Ellipta® dry powder inhaler: Design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers, Journal of Aerosol Medicine and Pulmonary Drug Delivery (2015)
- Once-daily single-inhaler triple versus dual therapy in patients with COPD, New England Journal of Medicine (2018)
- Anoro Ellipta, DailyMed (2023)
- Trelegy Ellipta, DailyMed (2023)